Age, education level, menopause status, cancer stage, comorbidities, hormone receptor status (estrogen receptor positive or negative, progesterone receptor positive or negative), HER2 positive or negative status, chemotherapy, hormone therapy, tamoxifen use, radiation therapy, smoking, alcohol consumption, body mass index, waist/hip ratio, parity. This evidence concerns the gene ERBB2 and cancer.